Dow Up 0.07% Nasdaq Up 0.61%

AbbVie Inc. (ABBV)

-NYSE
68.70 Up 0.64(0.94%) Nov 26, 4:00PM EST
|After Hours : 68.49 Down 0.21 (0.31%) Nov 26, 7:48PM EST
Prev Close:68.06
Open:68.34
Bid:67.88 x 400
Ask:68.99 x 100
1y Target Est:68.07
Beta:1.928
Earnings Date:Jan 29 - Feb 2 (Est.)
Day's Range:67.88 - 68.86
52wk Range:45.50 - 68.86
Volume:4,045,983
Avg Vol (3m):13,105,100
Market Cap:109.46B
P/E (ttm):29.87
EPS (ttm):2.30
Div & Yield:1.96 (2.90%)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for ABBV

Comparison

Symbol% ChgMkt Cap
ABBVUp 0.94%109.46B
MRKUp 0.69%170.34B
NVSUp 0.55%231.13B
PFEUp 2.07%195.95B

Key Statistics

Forward P/E (1 yr):16.13
P/S (ttm):5.53
Ex-Dividend Date:13-Jan-15

Analysts

Annual EPS Est (Dec-14) :3.30
Quarterly EPS Est (Dec-14) :0.86
Mean Recommendation*:2.1
PEG Ratio (5 yr expected):1.66

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceutical products worldwide. Its products include adult and pediatric pharmaceuticals, such as HUMIRA, a biologic therapy administered as a subcutaneous injection to treat autoimmune d... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback